TB-500 5mg Vial

At Futureproof, our TB-500 5mg is available for research use. TB-500 is a synthetic peptide based on thymosin beta-4, a natural peptide found in human cells. This synthetic version is used in laboratory settings to study processes linked to tissue repair, wound healing, and healing and recovery.
TB-500 is derived from an amino acid sequence that plays a role in cell migration and structural organisation. Research has focused on its involvement in regenerative medicine, including the formation of new blood vessels and the repair of damaged tissues.
 
Human Studies And Research Focus
Research on thymosin beta-4 has examined its role in wound healing, tissue repair, and injury recovery. Studies have looked at how cells move to an injection site and support healing in muscles tendons and ligaments.
Research areas include:
Wound healing
Tissue repair in damaged tissues
Formation of new blood vessels
Healing and recovery processes
Regenerative medicine models
 
Some studies suggest thymosin beta-4 supports the formation of new blood vessels and may influence how tissue responds after injury.
 
Biological Relevance
TB-500 is a synthetic peptide that reflects part of thymosin beta-4. This peptide is involved in actin regulation, which supports cell movement and structure. This process is important in tissue repair, wound healing, and recovery in muscles tendons and ligaments.
Research has examined:
Tissue repair and wound healing
Muscle growth and recovery
Formation of new blood vessels
Blood vessels and circulation models
Healing and recovery in connective tissue
 
Studies have also explored how thymosin beta-4 a natural peptide contributes to regenerative medicine and cellular repair pathways.
 
Areas Of Ongoing Research
Current laboratory research includes:
Tissue repair and regenerative medicine
Wound healing in damaged tissues
Muscle growth and recovery models
Blood vessels and angiogenesis
Performance enhancement related research
 
These areas remain under investigation and are not established for clinical use.
 
Administration Context In Research
Some experimental models reference administration at an injection site. These methods are limited to controlled laboratory environments and are not intended for clinical use.
For related peptide research, see our TB-500 10mg and GHK-Cu 50mg products.
 
Side Effects and Limitations
Research into TB-500 and thymosin beta-4 is ongoing. Data on side effects remains limited in human models. Long term effects are not fully established, and findings are restricted to controlled research settings.
 
Format and handling
TB-500 is supplied as a lyophilised peptide powder. Reconstitution is required prior to use, typically using bacteriostatic water in laboratory settings.
Handling conditions such as temperature control and avoiding repeated freeze and thaw cycles are important for maintaining peptide stability.
Our TB-500 5mg vial provides a measured format for laboratory research focused on tissue repair, wound healing, and regenerative processes.
Disclaimer: This product is sold strictly for research purposes only. It is not intended for medical, cosmetic, or therapeutic use. Not for human consumption.